ATE437865T1 - Flavanoide derivate als chemotherapeutika, chemopreventiva bzw. antiangiogenetische wirkstoffe - Google Patents

Flavanoide derivate als chemotherapeutika, chemopreventiva bzw. antiangiogenetische wirkstoffe

Info

Publication number
ATE437865T1
ATE437865T1 AT03724194T AT03724194T ATE437865T1 AT E437865 T1 ATE437865 T1 AT E437865T1 AT 03724194 T AT03724194 T AT 03724194T AT 03724194 T AT03724194 T AT 03724194T AT E437865 T1 ATE437865 T1 AT E437865T1
Authority
AT
Austria
Prior art keywords
sup
sub
alpha
absent
chemopreventives
Prior art date
Application number
AT03724194T
Other languages
English (en)
Inventor
Nurulain Zaveri
Wan-Ru Chao
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Application granted granted Critical
Publication of ATE437865T1 publication Critical patent/ATE437865T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT03724194T 2002-04-18 2003-04-18 Flavanoide derivate als chemotherapeutika, chemopreventiva bzw. antiangiogenetische wirkstoffe ATE437865T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/126,407 US20030229136A1 (en) 2002-04-18 2002-04-18 Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
PCT/US2003/012658 WO2003089423A2 (en) 2002-04-18 2003-04-18 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents

Publications (1)

Publication Number Publication Date
ATE437865T1 true ATE437865T1 (de) 2009-08-15

Family

ID=29248416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724194T ATE437865T1 (de) 2002-04-18 2003-04-18 Flavanoide derivate als chemotherapeutika, chemopreventiva bzw. antiangiogenetische wirkstoffe

Country Status (8)

Country Link
US (2) US20030229136A1 (de)
EP (1) EP1495014B1 (de)
JP (2) JP4610198B2 (de)
AT (1) ATE437865T1 (de)
AU (1) AU2003231069A1 (de)
CA (1) CA2484080C (de)
DE (1) DE60328593D1 (de)
WO (1) WO2003089423A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006298781A (ja) * 2005-04-15 2006-11-02 Geno Membrane:Kk エストロン３硫酸トランスポーター活性阻害剤
WO2011009826A2 (en) 2009-07-21 2011-01-27 ADAMED Sp.z o.o. Novel chalcone derivatives with cytotoxic activity
KR101220417B1 (ko) * 2010-11-04 2013-01-10 건국대학교 산학협력단 세포사멸 유도 활성을 갖는 칼콘 유도체
KR101283004B1 (ko) 2011-10-17 2013-07-05 건국대학교 산학협력단 벤조칼콘을 유효성분으로 포함하는 항암제 조성물
WO2013054998A1 (ko) * 2011-10-13 2013-04-18 건국대학교 산학협력단 신규한 칼콘 유도체 및 이를 유효성분으로 하는 항암제 조성물
WO2014007447A1 (ko) * 2012-07-03 2014-01-09 영남대학교 산학협력단 하이드록시 챨콘 화합물을 유효성분으로 함유하는 혈관신생으로 인한 질환의 예방 또는 치료용 조성물
CN102993157B (zh) * 2012-11-21 2015-04-01 上海交通大学 α-萘黄酮衍生物及其制备方法、用途
KR101524770B1 (ko) * 2013-08-29 2015-06-01 건국대학교 산학협력단 세포주기 조절을 통한 항암 효과를 보이는 폴리페놀
CN104059045B (zh) * 2014-05-27 2016-07-06 上海交通大学 水溶性α-萘黄酮醇衍生物及其制备方法、用途
PL233579B1 (pl) * 2017-09-21 2019-11-29 Univ Przyrodniczy We Wroclawiu 7-Izopropoksynaringenina, 7,4�-diizopropoksynaringenina i sposob jednoczesnego otrzymywania 7-izopropoksynaringeniny oraz 7,4�-diizopropoksynaringeniny
PL233278B1 (pl) * 2017-09-21 2019-09-30 Univ Przyrodniczy We Wroclawiu 5,7,4’-Tripropoksynaringenina i sposób otrzymywania 5,7,4’-tripropoksynaringeniny
CN108670966A (zh) * 2018-07-10 2018-10-19 浙江工业大学 二氢吡喃酮类化合物在制备抗肿瘤药物中的应用
CN108904491A (zh) * 2018-07-10 2018-11-30 浙江工业大学 一种黄烷酮类化合物在制备抗肿瘤药物中的应用
IL312547A (en) 2021-11-02 2024-07-01 Flare Therapeutics Inc PPARG inverse agonists and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787838R (fr) * 1971-08-25 1973-02-22 Delalande Sa Nouveaux derives du cinnamoyl-5 benzofuranne, leur procede de preparation et leur utilisation en therapeutique
JPH0617304B2 (ja) * 1982-09-09 1994-03-09 理化学研究所 制癌剤
USH1427H (en) 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
KR0139296B1 (ko) 1988-11-21 1998-05-15 가와무라 시게꾸니 칼콘 유도체 및 그 제조 방법
US6083978A (en) * 1996-03-05 2000-07-04 Sterix Limited Compounds with a sulfamate group
JPH0725761A (ja) 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
FR2748025B1 (fr) * 1996-04-25 1998-10-30 Adir Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant
KR100447918B1 (ko) * 1996-07-25 2005-09-28 동아제약주식회사 대장을포함한위장관보호작용을갖는플라본및플라바논화합물
GB9706202D0 (en) * 1997-03-25 1997-05-14 James Robinson Ltd Neutral colouring photochromic 2H-naphthol[1,2-b]pyrans and heterocyclic pyrans
DE19742025A1 (de) 1997-09-24 1999-03-25 Beiersdorf Ag Verwendung von Flavonen und Flavonoiden zur Hautaufhellung oder zur Verhinderung der durch oxidative Proteinaggregation hervorgerufenen Altersflecken
US5879592A (en) * 1997-12-10 1999-03-09 Ppg Industries, Inc. Water soluble photochromic compounds, compositions and optical elements comprising the compounds
DE19755504A1 (de) * 1997-12-13 1999-06-17 Beiersdorf Ag Verwendung von Flavonen und Flavonoiden gegen die UV-induzierte Zersetzung von Dibenzoylmethan und dessen Derivaten
FR2781153B1 (fr) * 1998-07-15 2001-08-03 Lafon Labor Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
US5961892A (en) * 1998-09-11 1999-10-05 Ppg Industries Ohio, Inc. Polyalkoxylated naphthopyrans
WO2001003681A2 (en) 1999-07-08 2001-01-18 Prendergast Patrick T Use of flavones, coumarins and related compounds to treat infections
GB9920908D0 (en) 1999-09-03 1999-11-10 Indena Spa Chalcone coumarins
GB9920910D0 (en) * 1999-09-03 1999-11-10 Indena Spa Novel chalcones
US6677350B1 (en) 1999-09-22 2004-01-13 Advanced Life Sciences, Inc. Beta-fluoroethyl thiourea compounds and use
WO2001021608A2 (en) 1999-09-23 2001-03-29 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Novel flavonoids
US20010047032A1 (en) 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
DE10053496A1 (de) * 2000-10-27 2002-05-08 Peter Fuerst Zusammensetzungen enthaltend Flavonoide und Phloridzin oder Phloretin
JP4813652B2 (ja) * 2000-12-04 2011-11-09 丸善製薬株式会社 マトリックスメタロプロテアーゼ阻害剤
KR100472694B1 (ko) * 2000-12-30 2005-03-07 한국생명공학연구원 플라바논 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물
US20020160983A1 (en) * 2001-03-16 2002-10-31 Alberto Bargiotti Substituted benzopyranones as telomerase inhibitors

Also Published As

Publication number Publication date
WO2003089423A3 (en) 2004-02-19
US20040029914A1 (en) 2004-02-12
CA2484080C (en) 2011-06-14
EP1495014A2 (de) 2005-01-12
EP1495014B1 (de) 2009-07-29
JP2005533760A (ja) 2005-11-10
JP2010138192A (ja) 2010-06-24
CA2484080A1 (en) 2003-10-30
AU2003231069A1 (en) 2003-11-03
JP4610198B2 (ja) 2011-01-12
WO2003089423A2 (en) 2003-10-30
US7329687B2 (en) 2008-02-12
US20030229136A1 (en) 2003-12-11
AU2003231069A8 (en) 2003-11-03
DE60328593D1 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
ATE437865T1 (de) Flavanoide derivate als chemotherapeutika, chemopreventiva bzw. antiangiogenetische wirkstoffe
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
ATE297203T1 (de) Antithrombotische mitteln
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
ATE306261T1 (de) Antithrombosemittel
EA200200374A1 (ru) Производные хинолилпропилпиперидина, их получение и содержащие их композиции
DE60307179D1 (de) Vor UV-Strahlen schützende Zusammensetzungen
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
SE0302760D0 (sv) New compounds
PT1349843E (pt) Derivados de tiazolo e de oxazolo como activadores dos receptores activados por proliferadores de peroxissomas humanos
MXPA04001240A (es) Analogos antitumorales.
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
DK1200426T3 (da) Substituerede thien-3-yl-sulfonylamino(thio)carbonyl-tiazolin(thi)oner
ATE241908T1 (de) Orale kombination von lufenuron und nitenpyram gegen flöhe
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DE60031886D1 (de) Purinderivate
DE50204884D1 (de) Kosmetische formulierung enthaltend dihydroxyaceton
AR053560A1 (es) Compuestos antibacterianos de 3,3' dialcoxi-2,2' -dihidroxi -1,1' -bifenilo 5,5' disustituidos y metodos relacionados
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
ATE308540T1 (de) Antithrombosemittel
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
RS51504B (en) FUNGICID COMPOSITIONS BASED ON PIRIDYL METHYLBENZAMIDE DERIVATIVES AND PROPAMOCARB
NO961797L (no) Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter
DK1250337T3 (da) Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties